North America Topical Drugs CDMO Market 2030: Why Semi-Solid Formulations Are Leading the Charge
The North American topical drugs CDMO market is experiencing a robust expansion, with an estimated value of USD 13.03 billion in 2023. This market is projected to surge at a compelling compound annual growth rate (CAGR) of 10.7% from 2024 to 2030. Several key factors are fueling this significant growth. These include a rising trend in healthcare outsourcing, a persistent drive for improved patient care, substantial R&D investments spurred by the increasing prevalence of various skin diseases, and the impending expiration of existing drug patents. Furthermore, the integration of advanced development and manufacturing technologies, coupled with the inherent cost-effectiveness offered by Contract Development and Manufacturing Organizations (CDMOs) and a growing number of these specialized firms, are positively influencing this market's trajectory. CDMOs stand out with their superior expertise and resources, particularly concerning clinical trials, and they offer more cost-effect...